drugset / Trial / NCT02863926

Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)

NCT02863926 ↗

Phase 1 Completed 6 enrolled Michael Murphy Zimmer Biomet · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Patients scheduled for major extremity lower amputation to receive bone marrow cells (cBMA) injected IM in the leg proximal to the amputation in the index limb to prevent ischemic wound complications after surgery.

Timeline

Start
2017-01-06
Primary completion
2018-07-27
Completion
2018-07-27

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject cBMA Unknown — —